{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:34:12Z","timestamp":1784590452824,"version":"3.55.0"},"reference-count":18,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Finding effective antiviral molecular strategies was a main concern in the scientific community when the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 as an easily transmissible and potentially deadly \u03b2-coronavirus able to cause the coronavirus disease 19 (COVID-19), which famously led to one of the most worrying pandemics in recent times. Other members of this zoonotic pathogenic family were already known before 2019, but apart from the SARS-CoV, which was responsible of severe acute respiratory syndrome (SARS) pandemic in 2002\/2003, and Middle East respiratory syndrome coronavirus (MERS-CoV), whose main impact on humans is geographically restricted to Middle Eastern countries, the other human \u03b2-coronaviruses known at that time were those typically associated with common cold symptoms which had not led to the development of any specific prophylactic or therapeutic measures. Although SARS-CoV-2 and its mutations are still causing illness in our communities, COVID-19 is less deadly than before and we are returning to normality. Overall, the main lesson learnt after the past few years of pandemic is that keeping our bodies healthy and immunity defenses strong using sport, nature-inspired measures, and using functional foods are powerful weapons for preventing the more severe forms of illness caused by SARS-CoV-2 and, from a more molecular perspective, that finding drugs with mechanisms of action involving biological targets conserved within the different mutations of SARS-CoV-2\u2014and possibly within the entire family of \u03b2-coronaviruses\u2014gives more therapeutic opportunities in the scenario of future pandemics based on these pathogens. In this regard, the main protease (Mpro), having no human homologues, offers a lower risk of off-target reactivity and represents a suitable therapeutic target in the search for efficacious, broad-spectrum anti-\u03b2-coronavirus drugs. Herein, we discuss on the above points and also report some molecular approaches presented in the past few years to counteract the effects of \u03b2-coronaviruses, with a special focus on SARS-CoV-2 but also MERS-CoV.<\/jats:p>","DOI":"10.3390\/molecules28052118","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T02:04:11Z","timestamp":1677463451000},"page":"2118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential Anti-SARS-CoV-2 Molecular Strategies"],"prefix":"10.3390","volume":"28","author":[{"given":"Caterina","family":"Vicidomini","sequence":"first","affiliation":[{"name":"Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-542X","authenticated-orcid":false,"given":"Giovanni N.","family":"Roviello","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Wan, X., Li, X., and Wan, C. (2022). Effects of a Shift of the Signal Peptide Cleavage Site in Signal Peptide Variant on the Synthesis and Secretion of SARS-CoV-2 Spike Protein. Molecules, 27.","DOI":"10.3390\/molecules27196688"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Jamsransuren, D., Makita, Y., Kaneko, A., Matsuda, S., Ogawa, H., and Oh, H. (2021). Inactivation Activities of Ozonated Water, Slightly Acidic Electrolyzed Water and Ethanol against SARS-CoV-2. Molecules, 26.","DOI":"10.3390\/molecules26185465"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Henri, J., Minder, L., Mohanasundaram, K., Dilly, S., Goupil-Lamy, A., Di Primo, C., and Slama Schwok, A. (2022). Neuropeptides, New Ligands of SARS-CoV-2 Nucleoprotein, a Potential Link between Replication, Inflammation and Neurotransmission. Molecules, 27.","DOI":"10.3390\/molecules27228094"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Costanzo, V., and Roviello, G.N. (2023). The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines, 11.","DOI":"10.3390\/vaccines11020333"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Islam, A., Bashir, M.S., Joyce, K., Rashid, H., Laher, I., and Elshazly, S. (2021). An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations. Molecules, 26.","DOI":"10.3390\/molecules26165004"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Villar, M., Urra, J.M., Artigas-Jer\u00f3nimo, S., Mazuecos, L., Contreras, M., Vaz-Rodrigues, R., Rodr\u00edguez-del-R\u00edo, F.J., Gort\u00e1zar, C., and de la Fuente, J. (2022). Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals. Molecules, 27.","DOI":"10.3390\/molecules27185933"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Mariniello, D.F., Allocca, V., D\u2019Agnano, V., Villaro, R., Lanata, L., Bagnasco, M., Aronne, L., Bianco, A., and Perrotta, F. (2022). Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?. Molecules, 27.","DOI":"10.3390\/molecules27248919"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Diniz, L.R.L., Elshabrawy, H.A., Souza, M.T.d.S., Duarte, A.B.S., Datta, S., and de Sousa, D.P. (2021). Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury. Molecules, 26.","DOI":"10.3390\/molecules26195951"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bouback, T.A., Pokhrel, S., Albeshri, A., Aljohani, A.M., Samad, A., Alam, R., Hossen, M.S., Al-Ghamdi, K., Talukder, M.E.K., and Ahammad, F. (2021). Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD. Molecules, 26.","DOI":"10.3390\/molecules26164961"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Qayed, W.S., Ferreira, R.S., and Silva, J.R.A. (2022). In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations. Molecules, 27.","DOI":"10.3390\/molecules27185988"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sur, V.P., Sen, M.K., and Komrskova, K. (2021). In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease. Molecules, 26.","DOI":"10.26434\/chemrxiv-2021-wk8d1"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Falanga, A.P., Terracciano, M., Oliviero, G., Roviello, G.N., and Borbone, N. (2022). Exploring the Relationship between G-Quadruplex Nucleic Acids and Plants: From Plant G-Quadruplex Function to Phytochemical G4 Ligands with Pharmaceutic Potential. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112377"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Greco, F., Musumeci, D., Borbone, N., Falanga, A.P., D\u2019Errico, S., Terracciano, M., Piccialli, I., Roviello, G.N., and Oliviero, G. (2022). Exploring the Parallel G-Quadruplex Nucleic Acid World: A Spectroscopic and Computational Investigation on the Binding of the c-myc Oncogene NHE III1 Region by the Phytochemical Polydatin. Molecules, 27.","DOI":"10.3390\/molecules27092997"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ricci, A., and Roviello, G.N. (2023). Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV. Life, 13.","DOI":"10.3390\/life13020402"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Adarshan, S., Akassh, S., Avinash, K., Bharathkumar, M., Muthuramalingam, P., Shin, H., Baskar, V., Chen, J.-T., Bhuvaneshwari, V., and Ramesh, M. (2022). Transcriptomics, Cheminformatics, and Systems Pharmacology Strategies Unveil the Potential Bioactives to Combat COVID-19. Molecules, 27.","DOI":"10.3390\/molecules27185955"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Eissa, I.H., Khalifa, M.M., Elkaeed, E.B., Hafez, E.E., Alsfouk, A.A., and Metwaly, A.M. (2021). In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules, 26.","DOI":"10.3390\/molecules26206151"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Tamura, K., Jamsransuren, D., Matsuda, S., and Ogawa, H. (2021). Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins. Molecules, 26.","DOI":"10.3390\/molecules26164803"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vicidomini, C., Roviello, V., and Roviello, G.N. (2021). Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility. Molecules, 26.","DOI":"10.3390\/molecules26071880"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/5\/2118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:41:28Z","timestamp":1760121688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/5\/2118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["molecules28052118"],"URL":"https:\/\/doi.org\/10.3390\/molecules28052118","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]}}}